Dr. Shahzad Raza, Hematologist, Seeing Patients at BCMH Outpatient Specialty Clinic
Bates County Memorial Hospital is pleased to announce Dr. Shahzad Raza, part of a team from St. Luke’s Health System, has joined Dr. Aimee Kohn, Oncologist, to provide services to patients at BCMH. Dr. Raza will see patients monthly in our Oncology/Hematology Clinic.
Dr. Raza is a board certified hematologist/oncologist and an expert in the field of malignant hematology. He joined Saint Luke’s Cancer Institute (SLCI) from New York Presbyterian Hospital/ Columbia University Medical Center, New York, an NCI designated comprehensive cancer center where he worked as Assistant Professor of Hematology & Oncology with a focus of treating complicated cases of multiple myeloma, AL Amyloidosis and malignant lymphomas.
He has also served as principal investigator and co-investigator for clinical trials including chemotherapies and immunotherapies that have aimed at developing new treatments for multiple myeloma and AL Amyloidosis.
Previously, Dr. Raza conducted his research on “Cancer therapies and Angiogenesis” under the mentorship of Michael L. Gruber M.D. and Silvia Formenti M.D. His published work on anti-angiogenic therapies was widely recognized and presented in multiple peer reviewed conferences including American Society of Clinical Oncology, American Society of Hematology, Society of Neuro-Oncology and American Society for therapeutic radiology and oncology. His research has been cited in top medical journals including New England Journal of Medicine, Lancet Oncology, British Journal of Hematology and many other journals. Dr. Raza is also an external reviewer for various top medical journals and serves as mentor for medical students, residents and fellows.
Due to his significant contribution to research and patient care, Dr. Raza was recognized as “Outstanding Fellow” by the State of Missouri. He was also awarded as “First Michael Perry Fellow Award” by the University of Missouri. In 2015, he was elected as “Fellow of American College of Physician (FACP)”, a distinction earned from colleagues recognizing accomplishments and achievements over and above the practice of medicine.
Dr. Raza believes in compassionate care for patients. His goal is to develop innovative clinical trials on immunotherapies, monoclonal antibodies, and novel small molecules in the management of multiple myeloma, lymphomas and leukemias.
Dr. Raza will start seeing patients at BCMH in October. To schedule an appointment with Dr. Raza, call the BCMH Outpatient Clinic at 660-200-7006.